T315I mutation of BCR-ABL1 into human Philadelphia chromosome-positive leukemia cell lines by homologous recombination using the CRISPR/Cas9 system
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
T315I mutation of BCR-ABL1 into human Philadelphia chromosome-positive leukemia cell lines by homologous recombination using the CRISPR/Cas9 system
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-06-26
DOI
10.1038/s41598-018-27767-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- How introns enhance gene expression
- (2017) Orit Shaul INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Enhanced CRISPR/Cas9-mediated precise genome editing by improved design and delivery of gRNA, Cas9 nuclease, and donor DNA
- (2017) Xiquan Liang et al. JOURNAL OF BIOTECHNOLOGY
- Gene expression and mutation-guided synthetic lethality eradicates proliferating and quiescent leukemia cells
- (2017) Margaret Nieborowska-Skorska et al. JOURNAL OF CLINICAL INVESTIGATION
- Drugging the Cancers Addicted to DNA Repair
- (2017) Jac A. Nickoloff et al. JNCI-Journal of the National Cancer Institute
- Simplified CRISPR tools for efficient genome editing and streamlined protocols for their delivery into mammalian cells and mouse zygotes
- (2017) Ashley M. Jacobi et al. METHODS
- PARP inhibitors: Synthetic lethality in the clinic
- (2017) Christopher J. Lord et al. SCIENCE
- Drugging the Cancers Addicted to DNA Repair
- (2017) Jac A. Nickoloff et al. JNCI-Journal of the National Cancer Institute
- RNA-Guided CRISPR-Cas9 System-Mediated Engineering of Acute Myeloid Leukemia Mutations
- (2017) Oliver Brabetz et al. Molecular Therapy-Nucleic Acids
- Genetic and Epigenetic Silencing of MicroRNA-203 Enhances ABL1 and BCR - ABL1 Oncogene Expression
- (2016) María J. Bueno et al. CANCER CELL
- Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9
- (2016) Dominik Paquet et al. NATURE
- Tyrosine kinase inhibitors in chronic myeloid leukaemia: which, when, for whom?
- (2016) Gianantonio Rosti et al. Nature Reviews Clinical Oncology
- Restoration of miR-424 suppresses BCR–ABL activity and sensitizes CML cells to imatinib treatment
- (2015) Oshrat Hershkovitz-Rokah et al. CANCER LETTERS
- MiR-30e induces apoptosis and sensitizes K562 cells to imatinib treatment via regulation of the BCR–ABL protein
- (2015) Oshrat Hershkovitz-Rokah et al. CANCER LETTERS
- Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining
- (2015) Takeshi Maruyama et al. NATURE BIOTECHNOLOGY
- Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells
- (2015) Van Trung Chu et al. NATURE BIOTECHNOLOGY
- Regulation of Gene Editing Activity Directed by Single-Stranded Oligonucleotides and CRISPR/Cas9 Systems
- (2015) Pawel Bialk et al. PLoS One
- Downregulation of BRCA1 protein in BCR-ABL1 leukemia cells depends on stress-triggered TIAR-mediated suppression of translation
- (2014) Paulina Podszywalow-Bartnicka et al. CELL CYCLE
- CRISPR-Cas systems for editing, regulating and targeting genomes
- (2014) Jeffry D Sander et al. NATURE BIOTECHNOLOGY
- RNA-Guided Human Genome Engineering via Cas9
- (2013) P. Mali et al. SCIENCE
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- (2013) L. Cong et al. SCIENCE
- Targeting RAD51 phosphotyrosine-315 to prevent unfaithful recombination repair in BCR-ABL1 leukemia
- (2011) A. Slupianek et al. BLOOD
- AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance
- (2009) Thomas O'Hare et al. CANCER CELL
- Widespread Shortening of 3′UTRs by Alternative Cleavage and Polyadenylation Activates Oncogenes in Cancer Cells
- (2009) Christine Mayr et al. CELL
- BCR-ABLGene Expression Is Required for Its Mutations in a Novel KCL-22 Cell Culture Model for Acquired Resistance of Chronic Myelogenous Leukemia
- (2009) Hongfeng Yuan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers
- (2009) Peter C. Fong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hypersensitivity of Ph-positive lymphoid cell lines to rapamycin: Possible clinical application of mTOR inhibitor
- (2008) Chikara Hirase et al. LEUKEMIA RESEARCH
- Proliferating Cells Express mRNAs with Shortened 3' Untranslated Regions and Fewer MicroRNA Target Sites
- (2008) R. Sandberg et al. SCIENCE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started